Published in J Clin Oncol on April 01, 2003
Inclusion of Elderly Patients With Colorectal Cancer in Clinical Trials (SAGE) | NCT01754636
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer | NCT01584544
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer (2004) 3.06
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma. Br J Cancer (2014) 2.26
The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst (2011) 2.00
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. Br J Cancer (2006) 1.99
Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med (2011) 1.92
Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol (2009) 1.74
Treating advanced non-small cell lung cancer in the elderly. Ther Adv Med Oncol (2010) 1.53
Patient income level and cancer clinical trial participation. J Clin Oncol (2013) 1.48
Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers. J Clin Oncol (2008) 1.34
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer (2006) 1.33
Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials. J Clin Oncol (2008) 1.33
Clinical trials: the art of enrollment. Semin Oncol Nurs (2008) 1.31
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer (2008) 1.29
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol (2010) 1.27
Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol (2005) 1.26
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer (2014) 1.25
Cancer survivorship and aging : moving the science forward. Cancer (2008) 1.23
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol (2009) 1.20
How does older age influence oncologists' cancer management? Oncologist (2010) 1.10
Barriers to enrollment of elderly adults in early-phase cancer clinical trials. J Oncol Pract (2008) 1.09
Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw (2012) 1.09
Cancer treatment disparities in HIV-infected individuals in the United States. J Clin Oncol (2014) 1.04
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One (2012) 1.04
Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments. J Geriatr Oncol (2011) 1.03
Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Canc Netw (2012) 1.01
Geriatric oncology: an overview of progresses and challenges. Cancer Res Treat (2010) 1.00
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations. Oncologist (2015) 0.99
Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. Osteoporos Int (2010) 0.99
Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study. Patient Educ Couns (2014) 0.97
Older cancer patients' information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs (2009) 0.97
Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health (2010) 0.97
The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. J Geriatr Oncol (2010) 0.97
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants. Med Care (2008) 0.96
Quality of Life in elderly patients with cancer. Health Qual Life Outcomes (2003) 0.95
Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia (2014) 0.95
The treatment of early breast cancer in women over the age of 70. Br J Cancer (2011) 0.95
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. Br J Cancer (2008) 0.94
Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials. J Health Care Poor Underserved (2009) 0.94
An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol (2011) 0.93
Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901. J Clin Oncol (2012) 0.93
Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol (2015) 0.93
Outcomes following local therapy for early-stage breast cancer in non-trial populations. Breast Cancer Res Treat (2010) 0.92
Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer. Strahlenther Onkol (2012) 0.92
Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist (2014) 0.92
Differences in the symptom experience of older oncology outpatients. J Pain Symptom Manage (2013) 0.91
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis. Br J Cancer (2013) 0.91
Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years. J Korean Med Sci (2012) 0.91
Lack of survival gain for elderly women with breast cancer. Oncologist (2011) 0.91
Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer. Cancer (2014) 0.91
Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist (2014) 0.91
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer (2012) 0.90
On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? Ann Oncol (2014) 0.89
Consent timing and experience: modifiable factors that may influence interest in clinical research. J Oncol Pract (2011) 0.89
Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma. Cancer (2011) 0.88
Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett (2013) 0.88
Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly. Cancer (2009) 0.87
Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer (2012) 0.87
Elderly patients' participation in clinical trials. Perspect Clin Res (2015) 0.87
Statewide cancer clinical trial navigation service. J Oncol Pract (2010) 0.86
The effect of care setting in the delivery of high-value colon cancer care. Cancer (2014) 0.86
Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer. Br J Cancer (2012) 0.85
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy. J Geriatr Oncol (2013) 0.85
Cardiovascular complications of breast cancer therapy in older adults. Oncologist (2011) 0.85
Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer. Cancer Res Treat (2007) 0.85
Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer. Gastric Cancer (2014) 0.85
Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer. Oncologist (2011) 0.85
Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy. J Cancer Res Clin Oncol (2010) 0.84
Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors. PLoS One (2015) 0.84
Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis. Cancer Res Treat (2011) 0.84
The value of observational cohort studies for cancer drugs. Biotechnol Healthc (2010) 0.83
Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden. Lung Cancer Int (2015) 0.82
An evaluation of elderly patients (≥70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011. J Geriatr Oncol (2013) 0.82
Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy. Head Neck (2015) 0.82
Combining extant datasets with differing outcome measures across studies of older adults after cancer surgery. Res Gerontol Nurs (2010) 0.82
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist (2012) 0.82
Colorectal cancer screening and surveillance in the elderly: updates and controversies. Gut Liver (2015) 0.81
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer. J Korean Med Sci (2005) 0.81
Do we protect or discriminate? Representation of senior adults in clinical trials. Rep Pract Oncol Radiother (2012) 0.81
Expert consensus panel guidelines on geriatric assessment in oncology. Eur J Cancer Care (Engl) (2015) 0.80
Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer (2015) 0.80
Age impacts the pattern of care for elderly patients with rectal cancer. Int J Colorectal Dis (2013) 0.80
Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article. Medicine (Baltimore) (2014) 0.79
The challenges of enrolling older adults into intervention studies. Yale J Biol Med (2013) 0.79
Multivariate analysis of the population representativeness of related clinical studies. J Biomed Inform (2016) 0.79
Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer. Cancer Res Treat (2012) 0.79
Participation of older patients with prostate cancer in Medicare eligible trials. J Urol (2010) 0.78
Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy. Oncotarget (2016) 0.78
The role of age on dose-limiting toxicities in phase I dose-escalation trials. Clin Cancer Res (2014) 0.78
Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer. Support Care Cancer (2016) 0.78
Patterns of care and treatment outcomes in older patients with biliary tract cancer. Oncotarget (2015) 0.77
Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer. Curr Oncol (2009) 0.77
Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base. Ther Adv Med Oncol (2015) 0.77
Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated? J Cancer Res Clin Oncol (2016) 0.77
Age-specific cancer survival in Estonia: recent trends and data quality. Clin Epidemiol (2015) 0.77
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol (2002) 6.51
Cost implications of reduced work hours and workloads for resident physicians. N Engl J Med (2009) 6.42
Employer drug benefit plans and spending on prescription drugs. JAMA (2002) 6.02
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol (2009) 5.37
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol (2002) 4.68
Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS (2009) 3.91
Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther (2007) 3.60
Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc (2006) 3.30
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther (2007) 3.27
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
Forecasting the nursing home population. Med Care (2003) 3.11
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
Neighborhood socioeconomic status and fruit and vegetable intake among whites, blacks, and Mexican Americans in the United States. Am J Clin Nutr (2008) 2.92
Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes (2009) 2.80
Immigrants and health care: sources of vulnerability. Health Aff (Millwood) (2007) 2.78
Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved (2002) 2.75
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet Oncol (2011) 2.71
How much is postacute care use affected by its availability? Health Serv Res (2005) 2.60
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One (2012) 2.53
Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res (2004) 2.50
The Women's Health Initiative: The food environment, neighborhood socioeconomic status, BMI, and blood pressure. Obesity (Silver Spring) (2011) 2.50
The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health (2009) 2.48
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res (2006) 2.44
Medicare's bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin. Health Aff (Millwood) (2011) 2.39
Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries. N Engl J Med (2002) 2.22
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) (2012) 2.16
Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J Acquir Immune Defic Syndr (2011) 2.16
Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. J Natl Cancer Inst (2013) 2.13
Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ (2013) 2.04
Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) (2013) 2.03
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst (2006) 2.01
Medicare spending and outcomes after postacute care for stroke and hip fracture. Med Care (2010) 1.99
Review: immigrants and health care access, quality, and cost. Med Care Res Rev (2009) 1.98
The role of product design in consumers' choices in the individual insurance market. Health Serv Res (2007) 1.98
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q (2009) 1.89
Neighbourhood socioeconomic status and biological 'wear and tear' in a nationally representative sample of US adults. J Epidemiol Community Health (2009) 1.89
Are the young becoming more disabled? Health Aff (Millwood) (2004) 1.88
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Neighborhood context and ethnicity differences in body mass index: a multilevel analysis using the NHANES III survey (1988-1994). Econ Hum Biol (2007) 1.82
The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) (2005) 1.79
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood) (2011) 1.71
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol (2008) 1.68
Developing predictive models of health literacy. J Gen Intern Med (2009) 1.66
The societal burden of osteoporosis. Curr Rheumatol Rep (2010) 1.65
EUS versus surgical cyst-gastrostomy for management of pancreatic pseudocysts. Gastrointest Endosc (2008) 1.64
Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLoS One (2011) 1.63
Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma. Gynecol Oncol (2006) 1.61
Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. J Acquir Immune Defic Syndr (2011) 1.56
Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa. Clin Infect Dis (2007) 1.55
Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol (2003) 1.55
Cancer Molecular Analysis Project: weaving a rich cancer research tapestry. Cancer Cell (2002) 1.53
Use of geocoding in managed care settings to identify quality disparities. Health Aff (Millwood) (2005) 1.52
Impact of specialty drugs on the use of other medical services. Am J Manag Care (2008) 1.51
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J Clin Oncol (2002) 1.50
Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect Dis (2012) 1.50
Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences. Health Serv Res (2007) 1.50
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood) (2008) 1.47
Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system. J Health Econ (2008) 1.45
Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res (2012) 1.44
Predictors for medical students entering a general surgery residency: National survey results. Surgery (2004) 1.43
Family structure and childhood obesity, Early Childhood Longitudinal Study - Kindergarten Cohort. Prev Chronic Dis (2010) 1.42
Economical and clinical outcomes of alternative treatment strategies in the management of common bile duct stones in the elderly: wait and see or surgery? Am J Gastroenterol (2006) 1.42
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township. BMC Infect Dis (2011) 1.40
PillCam ESO versus esophagogastroduodenoscopy in esophageal variceal screening: A decision analysis. J Clin Gastroenterol (2009) 1.39
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) (2012) 1.38
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One (2013) 1.35
Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev (2003) 1.32
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treat Rev (2011) 1.30
Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol (2003) 1.28
Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) (2007) 1.28
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res (2012) 1.27
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Impact of managed care on the treatment, costs, and outcomes of fee-for-service Medicare patients with acute myocardial infarction. Health Serv Res (2004) 1.27
Disability and health care spending among medicare beneficiaries. Health Aff (Millwood) (2005) 1.26
Effects of payment changes on trends in post-acute care. Health Serv Res (2009) 1.26
Updated variable-radius measures of hospital competition. Health Serv Res (2004) 1.26
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006. Breast Cancer Res Treat (2011) 1.24
Language access services for Latinos with limited English proficiency: lessons learned from Hablamos Juntos. J Gen Intern Med (2007) 1.24
The lifetime burden of chronic disease among the elderly. Health Aff (Millwood) (2005) 1.23
Endometrial cancer state of the science meeting. Int J Gynecol Cancer (2009) 1.23
Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol (2002) 1.23
Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA (2003) 1.22
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood) (2014) 1.21
Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol (2011) 1.20
Recent trends and geographic variation in the safety net. Med Care (2004) 1.20
Health services utilization after fractures: evidence from Medicare. J Gerontol A Biol Sci Med Sci (2010) 1.19
Community demographics and access to health care among U.S. Hispanics. Health Serv Res (2009) 1.17